| 000 | 01573 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250515092535.0 | ||
| 264 | 0 | _c20071206 | |
| 008 | 200712s 0 0 eng d | ||
| 022 | _a1083-7159 | ||
| 024 | 7 |
_a10.1634/theoncologist.12-10-1178 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeldner, Matthew | |
| 245 | 0 | 0 |
_aLocalized palmar-plantar epidermal hyperplasia: a previously undefined dermatologic toxicity to sorafenib. _h[electronic resource] |
| 260 |
_bThe oncologist _cOct 2007 |
||
| 300 |
_a1178-82 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenzenesulfonates _xadverse effects |
| 650 | 0 | 4 |
_aCarcinoma, Renal Cell _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 |
_aErythema _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aKidney Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPyridines _xadverse effects |
| 650 | 0 | 4 |
_aReceptors, Vascular Endothelial Growth Factor _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSkin Diseases _xchemically induced |
| 650 | 0 | 4 | _aSorafenib |
| 700 | 1 | _aJacobson, Michael | |
| 700 | 1 | _aBurges, Gene E | |
| 700 | 1 | _aDewaay, Deborah | |
| 700 | 1 | _aMaize, John C | |
| 700 | 1 | _aChaudhary, Uzair B | |
| 773 | 0 |
_tThe oncologist _gvol. 12 _gno. 10 _gp. 1178-82 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1634/theoncologist.12-10-1178 _zAvailable from publisher's website |
| 999 |
_c17481834 _d17481834 |
||